Skip to main content
. 2011 Jul 4;3:233–245. doi: 10.2147/CMR.S21033

Appendix.

Chemotherapy agents included in medication subclasses

Subclass Medication
Alkylating agents Bendamustine
Busulfan
Carmustine
Carmustine/polifeprosan
Chlorambucil
Cyclophosphamide
Dacarbazine
Estramustine
Ifosfamide
Lomustine
Mechlorethamine
Melphalan
Procarbazine
Streptozocin
Temozolomide
Thiotepa
Uracil mustard
Carboplatin
Cisplatin
Oxaliplatin
Antimetabolites Methotrexate
Pemetrexed
Cladribine
Clofarabine
Cytarabine
Fludarabine
Mercaptopurine
Nelarabine
Pentostatin
Thioguanine
Azacitidine
Capecitabine
Floxuridine
Fluorouracil
Gemcitabine
Hydroxyurea
Docetaxel (taxotere) Docetaxel
Other antimicrotubule agents Paclitaxel
Albumin-bound paclitaxel
Vinblastine
Vincristine
Vinorelbine
Ixabepilone
Topoisomerase-active agents Irinotecan
Topotecan
Daunorubicin
Doxorubicin
Pegylated liposomal
Doxorubicin
Epirubicin
Idarubicin
Mitoxantrone
Valrubicin
Etoposide
Teniposide
Antineoplastic antibiotics Bleomycin
Dactinomycin
Mitomycin C
Plicamycin
Biologically directed therapies Alitretinoin
Bexarotene
Bortezomib
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Sorafenib
Sunitinib
Temsirolimus
Tretinoin
Alemtuzumab
Bevacizumab
Cetuximab
Gemtuzumab
Ibritumomab
Panitumumab
Rituximab
Tositumomab
Trastuzumab
Immune therapies Aldesleukin (IL-2)
Interferon alfa-2a
Interferon alfa-2b
Lenalidomide
Thalidomide
Miscellaneous agents Altretamine
Arsenic trioxide
Asparaginase
Bcg vaccine
Decitabine
Denileukin
Levamisole
Mitotane
Pegaspargase
Porfimer
Strontium-89
Vorinostat
Zoledronic acid (zometa) Zoledronic acid